Document is current
Any future updates will be listed below
-
Authors
Hebrard, Bérénice
Babonneau, Marie-Lise
Charron, Philippe
Consolino, Emilie
Dauriat, Benjamin
Dupin-Deguine, Delphine
Fargeaud, Dominique
Farrugia, Agnès
Giguet-Valard, Anna-Gaëlle
Guijarro, Damien
Inamo, Jocelyn
Jeanneteau, Julien
Mazzella, Jean-Michaël
Michon, Claire-Cécile
Millat, Gilles
Mouquet, Frédéric
Oghina, Silvia
Pereon, Yann
Poinsignon, Vianney
Pompougnac, Julie
Proukhnitzky, Julie
Schaefer, Elise
Sturtz, Franck
Trosdorf, Mathilde
Auguste, Anne
Canali, Giorgia
Combes, Alexandre
Funalot, Benoît
Damy, Thibaud https://orcid.org/0000-0003-4058-3848
-
Funding
Funding for this research was provided by:
Pfizer France
- License Information
-
More Information
Article History
Received: 10 June 2024
Accepted: 18 September 2024
First Online: 29 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: BD, BF, BH, DG, EC, ES, FM, JPo, SO, TD and YP have received honoraria from Pfizer related to this work. BD has received honoraria from Pfizer. ES has received honoraria from Alnylam and Pfizer. FM has received honoraria from BMS and Pfizer. PC has received honoraria from Amicus, BMS, Owkin, Pfizer and Sanofi. SO has received honoraria from Pfizer. TD has received honoraria from Alexion, Alnylam, Akcea, Bridge Bio, Ionis, Neurimmune, Novo Nordisk and Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
